Changes to how Canada manages chemicals are under discussion, whether achieved by legislative and regulatory change or via policy actions. The parallel TSCA legislation in the US has already changed.

CEPA Update Conference and Workshops aims to help registrants understand:

  • What will change and when will I know it?
  • What will remain the same?
  • What are leading companies doing to comply with current requirements and anticipate new requirements?
  • What are the key opportunities for Canada/US & international regulatory cooperation?

Registrants will:

  • Obtain insights into the policy agenda from eminent speakers from Environment and Climate Change Canada, Health Canada, and leading companies via 3 well targeted Workshops and 2 days of Conference activities.
  • Meet and interact with the presenters.
  • Interact with leading suppliers and exhibitors aiming to help you comply and adapt.


  • Corporate managers with policy & compliance oversight for Canada
  • Regulatory compliance professionals
  • Association staff
  • Government officials involved in chemicals management and industry development
  • Service provider


Please click on the speakers to view their bios


Director, New Substances Assessment and Control
Health Canada

Maya is the Director of the New Substances Assessment and Control Bureau at Health Canada where she is responsible for conducting pre-market assessments of new chemicals, nanomaterials, and products of biotechnology (e.g., vaccines, microbial-based cleaning products and genetically modified organisms) before they enter Canadian commerce. Accountabilities include assessing the potential human health risks of new substances notified under CEPA and, where necessary, applying conditions or other controls on their use; assessing the human health risks and environmental impact of products regulated under the Food and Drugs Act (e.g., pharmaceuticals and veterinary drugs, cosmetics and natural health care products); furthering risk assessment science and methodologies; and contributing to the on-going delivery of the CMP.

Maya began her public service career in 1998 at Health Canada’s Environmental Health Directorate conducting human exposure assessments of existing substances. She then spent 17 years working at Environment and Climate Change Canada (ECCC) in a range of positions related to the risk assessment and risk management of new and existing substances.

Maya holds a B.Sc. in Environmental Sciences from McGill University, an M.Sc. in Environmental Sanitation from the University of Gent, and a Certificate in Public Management and Governance from the University of Ottawa.


Executive Director, Chemicals Management Division

Gwen Goodier is Executive Director of the Chemicals Management Division at Environment and Climate Change Canada, where she is responsible for the risk management of toxic substances under Canada’s chemicals management plan. Gwen has worked on all aspects of regulations, focusing on compliance promotion in her role as Director in the Environmental Protection Operations Directorate, then focusing on regulatory development and implementation as Director of the Waste Reduction and Management Division and in her current position, in the Industry Sectors, Chemicals and Waste Directorate. Gwen worked in the private sector for more than two decades prior to joining Environment and Climate Change 14 years ago.


President & CEO,
Chemistry Industry Association of Canada

Bob Masterson is President and CEO of the Chemistry Industry Association of Canada (CIAC). Reporting to the Board of Directors, he is responsible for executing the strategic direction and ongoing operations of the Association.


Director General, Safe Environments
Health Canada

David is Director General of the Safe Environments Directorate at Health Canada where he is responsible for implementing Canada's chemicals management system for new and existing substances from a human health perspective. Also included in his current mandate are drinking water standards, air quality standards, climate change adaptation, contaminated sites, and environmental site assessments from the perspective of impacts on human health.

Prior to joining Health Canada, David spent 17 years at Environment and Climate change Canada where he delivered on a range of topics related to chemicals risk assessment. His last five years at Environment Canada were as Director General of the Science and Risk Assessment Directorate where he was responsible for delivering on risk assessments for new and existing substances, Canada's PRTR, as well as Canada's National Inventory Report on GHG emissions.


Vice President, Regulatory and Technical Affairs
American Chemistry Council

Mike Walls has primary responsibility for the American Chemistry Council’s policy development. He began work in the Council’s Office of General Counsel, where he first provided legal advice on a range of international environmental, trade and product regulation issues. He has broad experience across a wide range of U.S. domestic chemical regulatory issues, including the Toxic Substances Control Act (TSCA). Before joining the Council Mike was in private law practice in Washington, D.C., and served on the staff of U.S. Senator Jim Sasser.


Deputy Director, Office of Pollution Prevention & Toxics US Envir. Protection Agency

Jeff Morris is Director of the United States Environmental Protection Agency’s Office of Pollution Prevention and Toxics, which regulates chemicals under the Toxic Substances Control Act, as well as administers the Pollution Prevention Act and manages the Toxics Release Inventory. During his career at EPA, Jeff has held positions in EPA’s Office of Pesticide Programs, Office of Research and Development, and Office of Pollution Prevention and Toxics.


Chair, Industry Coordinating Group
Arkema Canada

Robert Roth is currently the Technical & Regulatory Affairs Manager for Arkema Canada Inc. where his major responsibility is ensuring compliance with Canadian regulations. He also manages the Customer service, Logistics and Warehousing and Canada Customs compliance functions. He has worked with Environment Canada on risk assessments and development of risk management options for many substances including fluorochemicals, tin stabilizers, organic peroxides and PFCAs. Robert is Chair of the Industry Coordinating Group for CEPA (ICG) and the industry chair of the ICG Surveys sub-committee.


Chair, ICG Technical Subcommittee

Don Wilke is employed as a Principal Scientist with the Procter & Gamble Company, and holds a PhD in Pharmacology and Toxicology from Michigan State University. Don has over 33 years of experience in risk assessment, new substance notification and chemicals management in both U.S. and Canada. He has worked in CEPA-related issues for 25 years, and has served as a member of various Canadian consultative committees, including NSN-Reengineering and the CMP Science Committee. He also serves as co-chair of the ICG Technical Committee, where he provides technical direction and input in response to evolving CEPA and Chemicals Management Plan programs and initiatives.


Director, Ecological Assessment Division

Nicole Davidson has worked in the Federal Public Service for over 20 years in the area of risk assessment. She began her career at Health Canada in the New Substances program and for the last 19 years has been working at Environment and Climate Change Canada (ECCC). At ECCC, she has been responsible for the prioritization or categorization (ecological aspects) of the Domestic Substances List, as well as programs evaluating the risks to the environment from products of biotechnology, evaluating the risks to the environment from nanomaterials, developing environmental quality guidelines, coordinating research and monitoring activities related to the risk assessment and risk management of toxic substances and the risk assessment of Environment Canada’s contaminated sites. Nicole is currently is the Director of the Ecological Assessment Division responsible for delivering the ecological assessments of new and existing substances under the Canadian Environmental Protection Act, 1999.

Nicole graduated from McGill University with a B.Sc. in Biology and Environmental Sciences and from Concordia University with a graduate diploma in Ecotoxicology.


Director, Existing Substances Risk Assessment
Health Canada

Christine Norman holds a M.Sc. from McMaster University, Hamilton, Ontario. Christine has previously held leadership roles within Health Canada regulatory programs, including as Associate Director of the Consumer Product Safety program and in various positions within Health Canada’s Pest Management Regulatory Agency (PMRA). While at PMRA, Christine was responsible for human health risk assessments for pesticides being considered for registration in Canada and, in that capacity, she led federal initiatives related to children and environmental exposures. As part of the North American Free Trade Agreement’s Technical Working Group on Pesticides, she led many of the U.S. Environmental Protection Agency and Health Canada joint reviews of pesticides.

Since 2009, Christine has been the Director of the Existing Substances Risk Assessment Bureau. She also represents the Government of Canada on Organisation for Economic Cooperation and Development (OECD) Existing Chemicals Programme initiatives, is the Branch representative on the WHO Risk Assessment Network and leads risk assessment initiatives under the US/Canada Regulatory Cooperation Council.


Director General, Science and Risk Assessment Directorate

Jacqueline Gonçalves joined Environment and Climate Change Canada in the summer of 2016 as Director General, Science and Risk Assessment in the Science and Technology Branch. Prior to that she joined Health Canada in 2014 as the Director General of the Controlled Substances Directorate where she provided leadership, strategic direction, and operational guidance to regulate controlled substances and promote initiatives that prevent the harm associated with these substances. During her tenure, Ms. Gonçalves also served as the Head of the Canadian Delegation to the United Nations Commission on Narcotic Drugs.

Prior to joining Health Canada, Ms. Gonçalves served as the Director General, National Strategies (2010-2014), Canadian Coast Guard, a Special Operating Agency of the Department of Fisheries and Oceans Canada (DFO), where she oversaw the development of strategic policy and long-term strategies for the services of the Coast Guard, including many of the World Class Tanker Safety System initiatives.

Between February and September 2010, Jacqueline was the key advisor to the Deputy Minister in implementing the Departmental Reorganization.
Jacqueline holds a Master’s Degree in Public Policy and Public Administration as well as a Degree in Political Science from Concordia University, and a Science Degree in Human Physiology from McGill University.


Science Director,

The Dow Chemical Company

Bio coming soon...


Co-Chair, Chemicals Mgmt Plan Science Comm.
GC Granville Consulting Corp.

Bio coming soon...


Executive Director, Program Development & Engagement ECCC

Bio coming soon...